Summary
The non-specific activation of the immune system by administration of complete Freund's adjuvant was examined in Wistar rats as a possible means of amplification of the specific immune response directed to pancreatic β cells caused by low dose non-diabetogenic multiple injections of streptozotocin. Rats were given intraperitoneally 0.5 ml of complete Freund's adjuvant to induce polyclonal lymphocyte activation and, 1 day later, the animals were given an intraperitoneal injection of 15 mg streptozotocin/kg body weight (group 1). This combined treatment was given twice at weekly intervals. In two further groups, rats were treated with complete Freund's adjuvant alone (group 2) or streptozotocin alone (group 3) with the same doses and at the same times. Only the rats in group 1 developed delayed but severe and persistent hyperglycaemia. In addition, significant complement-dependent cytotoxicity was detected in nine out of 15 rats (60%) in group 1 in islet cells, but not in spleen lymphocytes. The pancreatic insulin content of the rats in group 1 was depleted by up to 3.1 ± 0.5%. With these experiments, a new animal model for insulin-dependent diabetes is described; complete Freund's adjuvant/streptozotocin diabetes. In many aspects, this model of diabetes parallels the development of insulin-dependent diabetes in man, including the humoral autoimmunity to islet cell antigens.
Article PDF
Similar content being viewed by others
References
Lernmark A, Freedman ZR, Hofmann C, Rubenstein AH, Steiner DR, Jackson RE, Winter RJ, Traisman HS (1978) Islet cell surface antibodies in juvenile diabetes mellitus. N Engl J Med 229: 375–380
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2: 1279–1282
Like AA, Rossini AA (1976) Streptozotocin-induced pancreatic insulitis: a new model of diabetes mellitus. Science 193: 415–417
Rossini AA, Like AA, Chick WL, Appel MC, Cahill GF (1977) Studies of streptozotocin-induced insulitis and diabetes. Proc Natl Acad Sci USA 74: 2485–2489
Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619–633
Paik SG, Blue ML, Fleischer N, Shin S (1982) Diabetes susceptibility of Balb/cBom mice treated with streptozotocin. Inhibition by lethal irradiation and restoration by splenic lymphocytes. Diabetes 31: 808–815
Rossini AA, Williams RM, Appel MC, Like AA (1978) Complete protection from low-dose streptozotocin-induced diabetes in mice. Nature 276:182–184
Leiter EH, Beamer WG, Schultz LD (1983) The effect of immunosuppression on streptozotocin-induced diabetes in C57BL/KsJ mice. Diabetes 32: 148–155
Ziegler M, Krabiell U, Georgi M (1977) Verfahren zur Isolierung von Peptiden und Eiweißen. DDR-Wirtschaftspatent, Patentschrift 125998: 1–5 (Patent office of GDR)
Hehmke B, Kohnert K-D, Dietz H, Zühlke H (1982) Cytotoxic effects of islet cell surface antibodies. Acta Biol Med Germ 41: 1117–1122
Orci L, Amherdt M, Malaisse-Lagae F, Ravazzola M, Malaisse WJ, Perrelet A, Renold AE (1976) Islet cell membrane alteration by diabetogenic drugs. Lab Invest 34: 451–454
Osebold W (1982) Mechanisms of action by immunologic adjuvants. J Am Vet Med Assoc 181: 983–987
Riley WJ, McConnell TJ, Maclaren NK, McLaughlin JV, Taylor G (1981) The diabetogenic effects of streptozotocin in mice are prolonged and inversely related to age. Diabetes 30: 718–723
Kolb H, Freytag G, Kiesel U, Kolb-Bachofen V (1981) Cellular immune reactions against pancreatic islets as a consequence of graft versus host disease. Clin exp Immunol 43: 121–127
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ziegler, M., Ziegler, B. & Hehmke, B. Severe hyperglycaemia caused by autoimmunization to β cells in rats. Diabetologia 27 (Suppl 1), 163–165 (1984). https://doi.org/10.1007/BF00275679
Issue Date:
DOI: https://doi.org/10.1007/BF00275679